These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7905387)

  • 1. Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
    Adusumalli VE; Wichmann JK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1993; 21(6):1079-85. PubMed ID: 7905387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier penetration of felbamate.
    Cornford EM; Young D; Paxton JW; Sofia RD
    Epilepsia; 1992; 33(5):944-54. PubMed ID: 1396440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of felbamate and four metabolites in rat cerebrospinal fluid by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    J Chromatogr; 1993 Dec; 622(2):223-8. PubMed ID: 8150869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate pharmacokinetics in the rat, rabbit, and dog.
    Adusumalli VE; Yang JT; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1116-25. PubMed ID: 1687019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of felbamate in brain.
    Cornford EM; Truong HV; Sofia RD; Kucharczyk N
    Epilepsia; 1996 Jan; 37(1):15-8. PubMed ID: 8603617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of felbamate and three metabolites in rat and dog plasmas by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    J Chromatogr; 1993 Dec; 622(2):229-34. PubMed ID: 8150870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of felbamate and three metabolites in human plasma by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    Ther Drug Monit; 1994 Feb; 16(1):83-9. PubMed ID: 8160261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
    Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
    Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of felbamate in pediatric and adult beagle dogs.
    Adusumalli VE; Gilchrist JR; Wichmann JK; Kucharczyk N; Sofia RD
    Epilepsia; 1992; 33(5):955-60. PubMed ID: 1396441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the anticonvulsant felbamate and its three metabolites in brain and heart tissue of rats.
    Jacala A; Adusumalli VE; Kucharczyk N; Sofia RD
    J Chromatogr; 1993 May; 614(2):285-92. PubMed ID: 8314941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
    McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro.
    Kapetanovic IM; Torchin CD; Thompson CD; Miller TA; McNeilly PJ; Macdonald TL; Kupferberg HJ; Perhach JL; Sofia RD; Strong JM
    Drug Metab Dispos; 1998 Nov; 26(11):1089-95. PubMed ID: 9806951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felbamate.
    Sofia RD; Kramer L; Perhach JL; Rosenberg A
    Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064
    [No Abstract]   [Full Text] [Related]  

  • 16. A mechanistic approach to understanding species differences in felbamate bioactivation: relevance to drug-induced idiosyncratic reactions.
    Dieckhaus CM; Miller TA; Sofia RD; Macdonald TL
    Drug Metab Dispos; 2000 Jul; 28(7):814-22. PubMed ID: 10859156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate metabolism in pediatric and adult beagle dogs.
    Yang JT; Morris M; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1992; 20(1):84-8. PubMed ID: 1347002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
    Steinhoff BJ
    Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug concentrations in human brain tissue samples from epileptic patients treated with felbamate.
    Adusumalli VE; Wichmann JK; Kucharczyk N; Kamin M; Sofia RD; French J; Sperling M; Bourgeois B; Devinsky O; Dreifuss FE
    Drug Metab Dispos; 1994; 22(1):168-70. PubMed ID: 8149879
    [No Abstract]   [Full Text] [Related]  

  • 20. Age and dose dependency of the pharmacokinetics and metabolism of bisphenol A in neonatal sprague-dawley rats following oral administration.
    Domoradzki JY; Thornton CM; Pottenger LH; Hansen SC; Card TL; Markham DA; Dryzga MD; Shiotsuka RN; Waechter JM
    Toxicol Sci; 2004 Feb; 77(2):230-42. PubMed ID: 14691203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.